KOLINPHARMA® signs an agreement with ASTAREAL® AB to distribute its products in the Asian market
KOLINPHARMA® has signed an important three-year agreement with the multinational ASTAREAL® AB to distribute its products in Mainland China, Hong Kong, Macao and Taiwan.
The agreement, based on the Cross Border Ecommerce Law that came into force in 2019, also commits Kolinpharma® and AstaReal® to make all the investments needed to set up the e-commerce and social media platforms, following a digital marketing plan and a long-term strategy defined by Kolinpharma®'s management together with the local expertise of the team at AstaReal®'s Shanghai office.
Rita Paola Petrelli, President of KOLINPHARMA®, commented: “We are proud to have sealed this very important partnership with the Swedish multinational, which is of strategic importance for Kolinpharma's international expansion. This agreement will allow us to begin significant commercial development in a market with great potential such as Asia. In China this market was worth CNY 114.4 billion in 2014 and is expected to reach CNY 328.2 billion (€47 billion) in 2023."

















